Comparison of Frequency of Use of Optive and Systane
NCT00406510
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Dry Eye
Interventions
DRUG:
Optive, Systane
Sponsor
Innovative Medical